BIOCYTOGEN-B Sets 16 September 2026 Hybrid EGM to Vote on Revised Use of Proceeds

Bulletin Express08-27

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (BIOCYTOGEN-B, 02315) will convene its third extraordinary general meeting (EGM) of 2026 at 2:00 p.m. on Wednesday, 16 September 2026. The meeting will adopt a hybrid format, combining a physical session at 12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Beijing, with an online webcast via the designated eVoting Portal (https://evoting.vistra.com).

The board will seek shareholder approval of a single ordinary resolution: a change in the implementation method of a proceeds-funded project. Full details are provided in the circular dated 27 August 2026, available on the HKEX and company websites.

Key administrative dates: • H-share register closure: Friday, 11 September 2026 to Wednesday, 16 September 2026 (both days inclusive). • Last day to lodge share transfers: 4:30 p.m. on Thursday, 10 September 2026 at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. • Proxy submission deadline: 2:00 p.m. on Tuesday, 15 September 2026, or at least 24 hours before any adjourned meeting.

All resolutions will be decided by poll, and results will be published on HKEXnews and the company website in accordance with listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120994792?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120994792","market":"us","top_or_hot":-1,"title":"BIOCYTOGEN-B Sets 16 September 2026 Hybrid EGM to Vote on Revised Use of Proceeds","media":"Bulletin Express","content":"<p>Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (BIOCYTOGEN-B, 02315) will convene its third extraordinary general meeting (EGM) of 2026 at 2:00 p.m. on Wednesday, 16 September 2026. The meeting will adopt a hybrid format, combining a physical session at 12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Beijing, with an online webcast via the designated eVoting Portal (https://evoting.vistra.com).</p>\n<p>The board will seek shareholder approval of a single ordinary resolution: a change in the implementation method of a proceeds-funded project. Full details are provided in the circular dated 27 August 2026, available on the HKEX and company websites.</p>\n<p>Key administrative dates:\n• H-share register closure: Friday, 11 September 2026 to Wednesday, 16 September 2026 (both days inclusive).  \n• Last day to lodge share transfers: 4:30 p.m. on Thursday, 10 September 2026 at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission deadline: 2:00 p.m. on Tuesday, 15 September 2026, or at least 24 hours before any adjourned meeting.</p>\n<p>All resolutions will be decided by poll, and results will be published on HKEXnews and the company website in accordance with listing rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOCYTOGEN-B Sets 16 September 2026 Hybrid EGM to Vote on Revised Use of Proceeds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOCYTOGEN-B Sets 16 September 2026 Hybrid EGM to Vote on Revised Use of Proceeds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-27 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (BIOCYTOGEN-B, 02315) will convene its third extraordinary general meeting (EGM) of 2026 at 2:00 p.m. on Wednesday, 16 September 2026. The meeting will adopt a hybrid format, combining a physical session at 12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Beijing, with an online webcast via the designated eVoting Portal (https://evoting.vistra.com).</p>\n<p>The board will seek shareholder approval of a single ordinary resolution: a change in the implementation method of a proceeds-funded project. Full details are provided in the circular dated 27 August 2026, available on the HKEX and company websites.</p>\n<p>Key administrative dates:\n• H-share register closure: Friday, 11 September 2026 to Wednesday, 16 September 2026 (both days inclusive).  \n• Last day to lodge share transfers: 4:30 p.m. on Thursday, 10 September 2026 at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission deadline: 2:00 p.m. on Tuesday, 15 September 2026, or at least 24 hours before any adjourned meeting.</p>\n<p>All resolutions will be decided by poll, and results will be published on HKEXnews and the company website in accordance with listing rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"","article_id":"1120994792","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120994792","pubTimestamp":1787820177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (BIOCYTOGEN-B, 02315) will convene its third extraordinary general meeting (EGM) of 2026 at 2:00 p.m. on Wednesday, 16 September 2026. The meeting will...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02315":"百奥赛图-B"},"translate_title":"BIOCYTOGEN-B 将于 2026 年 9 月 16 日举行混合特别股东大会，就修订所得款项用途进行投票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (BIOCYTOGEN-B, 02315) will convene its third extraordinary general meeting (EGM) of 2026 at 2:00 p.m. on Wednesday, 16 September 2026. The meeting will adopt a hybrid format, combining a physical session at 12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Beijing, with an online webcast via the designated eVoting Portal (https://evoting.vistra.com).\nThe board will seek shareholder approval of a single ordinary resolution: a change in the implementation method of a proceeds-funded project. Full details are provided in the circular dated 27 August 2026, available on the HKEX and company websites.\nKey administrative dates:\n• H-share register closure: Friday, 11 September 2026 to Wednesday, 16 September 2026 (both days inclusive).  \n• Last day to lodge share transfers: 4:30 p.m. on Thursday, 10 September 2026 at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission deadline: 2:00 p.m. on Tuesday, 15 September 2026, or at least 24 hours before any adjourned meeting.\nAll resolutions will be decided by poll, and results will be published on HKEXnews and the company website in accordance with listing rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120994792","isCrawlerRequest":true}